Literature DB >> 12765884

Old dog--new (ma)trix.

K Budd, B J Collett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12765884     DOI： 10.1093/bja/aeg133

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  7 in total

1.  Treatment of cancer-related pain with transdermal buprenorphine: a report of three cases.

Authors:  Paul Schriek
Journal:  Support Care Cancer       Date:  2004-10-09       Impact factor: 3.603

Review 2.  Role of active metabolites in the use of opioids.

Authors:  Janet K Coller; Lona L Christrup; Andrew A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  2008-10-29       Impact factor: 2.953

3.  Buprenorphine: a unique drug with complex pharmacology.

Authors:  Kabirullah Lutfy; Alan Cowan
Journal:  Curr Neuropharmacol       Date:  2004-10       Impact factor: 7.363

4.  Pharmacokinetic-pharmacodynamic modeling of the effectiveness and safety of buprenorphine and fentanyl in rats.

Authors:  Ashraf Yassen; Erik Olofsen; Jingmin Kan; Albert Dahan; Meindert Danhof
Journal:  Pharm Res       Date:  2007-10-04       Impact factor: 4.200

5.  Modeling buprenorphine reduction of fentanyl-induced respiratory depression.

Authors:  Erik Olofsen; Marijke Hyke Algera; Laurence Moss; Robert L Dobbins; Geert J Groeneveld; Monique van Velzen; Marieke Niesters; Albert Dahan; Celine M Laffont
Journal:  JCI Insight       Date:  2022-05-09

Review 6.  Management of chronic pain in the elderly: focus on transdermal buprenorphine.

Authors:  Nalini Vadivelu; Roberta L Hines
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

7.  Transdermal buprenorphine in the management of persistent pain - safety aspects.

Authors:  Rudolf Likar
Journal:  Ther Clin Risk Manag       Date:  2006-03       Impact factor: 2.423
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.